This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FEF33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The $1,308.51 firm fixed-price delivery order is for the supply of NAMZARIC 28 MG-10 MG capsules with an ultimate completion date of November 14, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valid through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, covering similar medical products and prescription drugs through May 2024.
Generated 2/12/25, 9:28 AM